Biogen
BIIB
BIIB
992 hedge funds and large institutions have $50.9B invested in Biogen in 2017 Q2 according to their latest regulatory filings, with 79 funds opening new positions, 351 increasing their positions, 391 reducing their positions, and 96 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
15% less funds holding in top 10
Funds holding in top 10: 27 → 23 (-4)
16% less call options, than puts
Call options by funds: $954M | Put options by funds: $1.14B
18% less first-time investments, than exits
New positions opened: 79 | Existing positions closed: 96
Holders
992
Holding in Top 10
23
Calls
$954M
Puts
$1.14B
Top Buyers
| 1 | +$384M | |
| 2 | +$225M | |
| 3 | +$188M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$183M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$152M |
Top Sellers
| 1 | -$364M | |
| 2 | -$325M | |
| 3 | -$189M | |
| 4 |
Viking Global Investors
Stamford,
Connecticut
|
-$188M |
| 5 |
UBS AM
Chicago,
Illinois
|
-$170M |